[2]
Taylor AL,Ziesche S,Yancy C,Carson P,D'Agostino R Jr,Ferdinand K,Taylor M,Adams K,Sabolinski M,Worcel M,Cohn JN, Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. The New England journal of medicine. 2004 Nov 11; [PubMed PMID: 15533851]
[3]
Bortolotti M,Coccia G,Brunelli F,Sarti P,Mazza M,Bagnato F,Barbara L, Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia? The Italian journal of gastroenterology. 1994 Oct-Nov; [PubMed PMID: 7703511]
[4]
Gelfond M,Rozen P,Gilat T, Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. 1982 Nov; [PubMed PMID: 6288509]
[5]
Roman S,Kahrilas PJ, Management of spastic disorders of the esophagus. Gastroenterology clinics of North America. 2013 Mar; [PubMed PMID: 23452629]
[6]
Miñano C,Garcia-Tsao G, Clinical pharmacology of portal hypertension. Gastroenterology clinics of North America. 2010 Sep; [PubMed PMID: 20951924]
[7]
Daiber A,Münzel T, Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress. Antioxidants [PubMed PMID: 26261901]
[8]
Etter EF,Eto M,Wardle RL,Brautigan DL,Murphy RA, Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. The Journal of biological chemistry. 2001 Sep 14; [PubMed PMID: 11461918]
[9]
Lincoln TM,Komalavilas P,Cornwell TL, Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension (Dallas, Tex. : 1979). 1994 Jun; [PubMed PMID: 8206604]
[10]
Divakaran S,Loscalzo J, The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics. Journal of the American College of Cardiology. 2017 Nov 7 [PubMed PMID: 29096811]
[11]
Tarkin JM,Kaski JC, Vasodilator Therapy: Nitrates and Nicorandil. Cardiovascular drugs and therapy. 2016 Aug; [PubMed PMID: 27311574]
[12]
Leier CV,Huss P,Magorien RD,Unverferth DV, Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983 Apr; [PubMed PMID: 6337742]
[13]
Fung HL, Pharmacokinetics and pharmacodynamics of isosorbide dinitrate. American heart journal. 1985 Jul; [PubMed PMID: 4013997]
[14]
Laufen H,Aumann M,Leitold M, Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man. Arzneimittel-Forschung. 1983; [PubMed PMID: 6684933]
[15]
Abshagen UW, Pharmacokinetics of isosorbide mononitrate. The American journal of cardiology. 1992 Nov 27; [PubMed PMID: 1449102]
[16]
Thadani U,Whitsett T, Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clinical pharmacokinetics. 1988 Jul; [PubMed PMID: 3135973]
[17]
Sisenwine SF,Ruelius HW, Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog. The Journal of pharmacology and experimental therapeutics. 1971 Feb; [PubMed PMID: 5568780]
[18]
Boden WE,Finn AV,Patel D,Peacock WF,Thadani U,Zimmerman FH, Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clinical cardiology. 2012 May; [PubMed PMID: 22528319]
[19]
Parker JD,Parker JO, Nitrate therapy for stable angina pectoris. The New England journal of medicine. 1998 Feb 19; [PubMed PMID: 9468470]
[20]
Echols MR,Yancy CW, Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure. Vascular health and risk management. 2006; [PubMed PMID: 17323596]
[21]
Christiansen I,Iversen HK,Olesen J, Headache characteristics during the development of tolerance to nitrates: pathophysiological implications. Cephalalgia : an international journal of headache. 2000 Jun; [PubMed PMID: 11037739]
[22]
Thadani U,Rodgers T, Side effects of using nitrates to treat angina. Expert opinion on drug safety. 2006 Sep; [PubMed PMID: 16907656]
[23]
Inal ME,Egüz AM, The effects of isosorbide dinitrate on methemoglobin reductase enzyme activity and antioxidant states. Cell biochemistry and function. 2004 Mar-Apr; [PubMed PMID: 15027102]
[24]
Khaybullina D,Patel A,Zerilli T, Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. P [PubMed PMID: 25395817]
[25]
do Nascimento TS,Pereira RO,de Mello HL,Costa J, Methemoglobinemia: from diagnosis to treatment. Revista brasileira de anestesiologia. 2008 Nov-Dec; [PubMed PMID: 19082413]
[26]
Münzel T,Steven S,Daiber A, Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction. Vascular pharmacology. 2014 Dec; [PubMed PMID: 25446162]
[27]
Kośmicki M,Sadowski Z,Szwed H,Kowalik I, What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance? Medical science monitor : international medical journal of experimental and clinical research. 2000 Jul-Aug; [PubMed PMID: 11208406]